Perceptive And Xontogeny’s Second VC Fund Brings In $515m
Fund II Is More Than Double Their $210m Fund I In 2019
The strategy for both funds is to back companies with a preclinical drug candidate that can be advanced through clinical proof-of-concept with a mid-sized series A round.
